Trials / Completed
CompletedNCT00944242
Bioequivalence Study of Sertraline 100 mg Tablet and ZOLOFT Following a 100 mg Dose in Healthy Subjects Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Torrent Pharmaceuticals Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
* Objective: * To compare the rate and extent of absorption of Torrent Pharmaceuticals Limited, India, sertraline and Pfizer, Inc., USA (Zoloft) sertraline, administered as a 1X100 mg tablet, under fasted conditions. * Study Design: * Single-dose, open-label, randomized two-way crossover.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sertraline | |
| DRUG | Sertraline Hydrochloride |
Timeline
- First posted
- 2009-07-23
- Last updated
- 2009-07-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00944242. Inclusion in this directory is not an endorsement.